SCCA News2012 | 2011 | | 2009 | 2008 | 2007
The Seattle Times reports today on a new drug that SCCA's Andrei Shustov calls a "major breakthrough in T-cell lymphoma therapy." The drug, SGN-35, targets malignant cancer cells and stops them from dividing. The drug was developed by Seattle Genetics, which plans to apply to the FDA for conditional approval of SGN-35 in the first half of 2011
Related Diseases: Non-Hodgkin’s Lymphoma, Hodgkin's Lymphoma
Women with a personal history of breast cancer should consider annual screening with MRI in addition to mammography, according to a study presented at the annual meeting of the Radiological Society of North America (RSNA). The authors of the study including SCCA's Drs. Wendy DeMartini, Peter Eby, Robert Gutierrez, and Constance Lehman
Related Diseases: Medical Imaging & Procedures
The American Cancer Society announced today that Dr. Tony Back received the Pathfinder in Palliative Care Award in recognition of his tireless personal passion for promoting palliative care and patient quality of life
American Cancer Society Honors
A new study finds that post-menopausal women who use hormone-replacement therapy are at a greater risk of getting aggressive cancers than those who don't. Gwen Ifill gets perspectives on the findings from the lead author of the study, Dr. Rowan Chlebowski, and SCCA's Dr. Julie Gralow
KING-5 TV reporter Jean Enersen looks at how SCCA surgeon Dr. Eduardo Mendez uses the Da Vinci Robot to treat patients with head and throat cancers.
Fred Hutchinson Cancer Research Center announces the selection of Lawrence Corey, M.D., an internationally renowned expert in virology, immunology and vaccine development, as its new president and director.
Bozeman Deaconess Hospital in Bozeman, Montana, has joined the SCCA Network to become the ninth Northwest community healthcare facility to enter into an affiliation agreement with SCCA.
Bozeman Deaconess Joins SCCA Affiliate Network
An Oregon man beat advanced melanoma—the deadliest of skin cancers—with nothing but his own cancer-fighting immune cells that had been multiplied in the lab. Read about this and other revolutionary immunotherapies in Fred Hutchinson Cancer Research Center's latest edition of "Quest" magazine.
Related Diseases: Melanoma